日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients

sGCa Vericiguat 通过 NLRP-3 通路发挥心脏保护和抗肌肉减少作用:对接受蒽环类药物治疗的癌症患者有潜在益处

Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, Ilaria Giacobbe, Martina Iovine, Vienna Giordano, Raffaele Arianna, Matteo Barbato, Francesca Izzo, Carlo Maurea, Maria Laura Canale, Andrea Paccone, Alessandro Inno, Marino Scherillo, Domenico Gabrielli, Nicola Maurea

Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways

免疫检查点抑制剂疗法可增加全身 SDF-1、心脏 DAMP、纤连蛋白-EDA、S100/钙粒蛋白、半乳糖凝集素-3 和 NLRP3-MyD88-趋化因子通路

Vincenzo Quagliariello, Margherita Passariello, Annabella Di Mauro, Ciro Cipullo, Andrea Paccone, Antonio Barbieri, Giuseppe Palma, Antonio Luciano, Simona Buccolo, Irma Bisceglia, Maria Laura Canale, Giuseppina Gallucci, Alessandro Inno, Claudia De Lorenzo, Nicola Maurea